LIBTAYO 350 mg concentrate for solution for infusion., IMUNOCARE 5% crema
IOR-REG-2501
Phase 2 small_molecule active
Quick answer
LIBTAYO 350 mg concentrate for solution for infusion., IMUNOCARE 5% crema for Cutaneous Basal Cell Carcinoma is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Cutaneous Basal Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active